Starting in the 1990’s, cytokines, drugs that stimulate bone marrow to produce infection-fighting white blood cells, began to be integrated into cancer treatments, further mitigating the risk of life-threatening infectious complications of care.
Dies führte zur Entwicklung und den verbesserten Einsatz wirksamerer Antibiotika.